Baumgardner in JMCP: Is OCM Episode-Based Spending Associated with Patient Outcomes?


PHE Senior Research Economist James Baumgardner, PhD, and colleagues conducted an analysis aimed at determining whether spending within oncology care episodes is associated with survival. Researchers utilized evidence from geographic variations in spending and individual-level survival.  The results were recently published in the Journal of Managed Care & Specialty Pharmacy (2018;24[6]:504-513).

To read recent press coverage of Dr. Baumgartner’s study, as well as the study itself, please click below:

Journal of Clinical Pathways

Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.